Immediate vs. Delayed Insertion of Copper T 380A IUD After Termination of Pregnancy Over 12-weeks Gestation
Study Details
Study Description
Brief Summary
The purpose of this study is to compare delayed vs. immediate insertion of the Copper T 380 IUD after termination of pregnancy after 12 weeks.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
N/A |
Detailed Description
Patients presenting to ParkMed Women's Clinic and the Reproductive Choice clinic at Bellevue Hospital for second trimester termination will be offered participation in this study. They will be randomized to either delayed or immediate Copper T 380A IUD insertion. The subjects will be seen at a 6 month follow-up visit and Copper T 380A IUD placement will be verified by physical exam. At this 6 month follow-up visit, subjects will fill out a satisfaction questionnaire.
Study Design
Arms and Interventions
Arm | Intervention/Treatment |
---|---|
Active Comparator: A/Immediate The patients in the immediate arm will have the Copper T 380A IUD inserted within 15 minutes after delivery of the placenta immediately following procedure |
Device: Copper T 380A IUD
Copper T 380A IUD will be placed at the 2-4 week post-operative visit.
|
Active Comparator: B/Delayed The delayed group will have the Copper T 380A IUD inserted at the post-operative visit within 2-4 weeks following the procedure. |
Device: Copper T 380A IUD
Copper T 380A IUD will be placed at the 2-4 week post-operative visit.
|
Outcome Measures
Primary Outcome Measures
- Use of IUD [6 months]
Number of participants using Copper T380A IUD 6 months after surgery
Secondary Outcome Measures
- Expulsion [6 months]
IUD was not removed by provider but fell out on its own.
Eligibility Criteria
Criteria
Inclusion Criteria:
-
women 16 years of age and older
-
intrauterine pregnancy > 14 weeks gestation
-
desires termination of pregnancy
-
desires IUD for contraception
-
ability to give informed consent
-
no contraindication for D+E
Exclusion Criteria:
-
unable to give informed consent
-
less than 16 years of age
-
congenital or acquired uterine anomaly including fibroids if they distort the uterine cavity
-
acute pelvic inflammatory disease (PID)
-
known or suspected uterine or cervical neoplasia or unresolved abnormal PAP smear
-
untreated acute cervicitis or vaginitis, until infection treated/controlled
-
confirmed Chlamydia trachomatis or Neisseria gonorrhea infection in the previous 90 days
-
acute liver disease or liver tumor (benign or malignant)
-
woman or partner currently with multiple sexual partners
-
history of Wilson's disease
-
hypersensitivity to any component of Copper T IUD
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | Bellevue Hospital | New York | New York | United States | 10016 |
2 | Parkmed Women's Clinic | New York | New York | United States | 10017 |
Sponsors and Collaborators
- NYU Langone Health
- Icahn School of Medicine at Mount Sinai
Investigators
- Principal Investigator: Miriam L. Cremer, MD, MPH, Icahn School of Medicine at Mount Sinai
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- Post Abortion Copper T IUD
Study Results
Participant Flow
Recruitment Details | |
---|---|
Pre-assignment Detail |
Arm/Group Title | A/Immediate | B/Delayed |
---|---|---|
Arm/Group Description | The patients in the immediate arm will have the Copper T 380A IUD inserted within 15 minutes after delivery of the placenta immediately following procedure Copper T 380A IUD: Copper T 380A IUD will be placed immediately following the procedure. | The delayed group will have the Copper T 380A IUD inserted at the post-operative visit within 2-4 weeks following the procedure. Copper T 380A IUD: Copper T 380A IUD will be placed at the 2-4 week post-operative visit. |
Period Title: Overall Study | ||
STARTED | 104 | 111 |
COMPLETED | 71 | 88 |
NOT COMPLETED | 33 | 23 |
Baseline Characteristics
Arm/Group Title | A/Immediate | B/Delayed | Total |
---|---|---|---|
Arm/Group Description | The patients in the immediate arm will have the Copper T 380A IUD inserted within 15 minutes after delivery of the placenta immediately following procedure Copper T 380A IUD: Copper T 380A IUD will be placed immediately following the procedure. | The delayed group will have the Copper T 380A IUD inserted at the post-operative visit within 2-4 weeks following the procedure. Copper T 380A IUD: Copper T 380A IUD will be placed at the 2-4 week post-operative visit. | Total of all reporting groups |
Overall Participants | 104 | 111 | 215 |
Age (years) [Mean (Full Range) ] | |||
Mean (Full Range) [years] |
24
|
23.4
|
23.7
|
Sex/Gender, Customized (participants) [Number] | |||
Female |
104
100%
|
111
100%
|
215
100%
|
Race/Ethnicity, Customized (participants) [Number] | |||
Black |
48
46.2%
|
52
46.8%
|
100
46.5%
|
Hispanic or Latino |
43
41.3%
|
39
35.1%
|
82
38.1%
|
White |
4
3.8%
|
6
5.4%
|
10
4.7%
|
Asian or South Asian |
1
1%
|
4
3.6%
|
5
2.3%
|
Mixed |
4
3.8%
|
5
4.5%
|
9
4.2%
|
Other |
2
1.9%
|
3
2.7%
|
5
2.3%
|
Missing |
2
1.9%
|
2
1.8%
|
4
1.9%
|
Gestational age (weeks) [Mean (Full Range) ] | |||
Mean (Full Range) [weeks] |
19.2
|
18.8
|
19.0
|
Outcome Measures
Title | Use of IUD |
---|---|
Description | Number of participants using Copper T380A IUD 6 months after surgery |
Time Frame | 6 months |
Outcome Measure Data
Analysis Population Description |
---|
[Not Specified] |
Arm/Group Title | A/Immediate | B/Delayed |
---|---|---|
Arm/Group Description | The patients in the immediate arm will have the Copper T 380A IUD inserted within 15 minutes after delivery of the placenta immediately following procedure Copper T 380A IUD: Copper T 380A IUD will be placed immediately following the procedure. | The delayed group will have the Copper T 380A IUD inserted at the post-operative visit within 2-4 weeks following the procedure. Copper T 380A IUD: Copper T 380A IUD will be placed at the 2-4 week post-operative visit. |
Measure Participants | 71 | 88 |
Number [participants] |
58
55.8%
|
25
22.5%
|
Title | Expulsion |
---|---|
Description | IUD was not removed by provider but fell out on its own. |
Time Frame | 6 months |
Outcome Measure Data
Analysis Population Description |
---|
The analysis here includes the 64/71 A/Immediate arm and 26/88 B/Delayed arm who received an IUD. In the A/Immediate arm, 5 women changed their mind post-randomization and in 2 cases, the provider chose not to place it. In the B/Delayed arm, reasons included not returning for follow-up visit, changing mind, and provider not wanting to place IUD. |
Arm/Group Title | A/Immediate | B/Delayed |
---|---|---|
Arm/Group Description | The patients in the immediate arm had the Copper T 380A IUD inserted within 15 minutes after delivery of the placenta immediately following procedure. IUD status was known six months post-abortion and insertion. | The delayed group had the Copper T 380A IUD inserted at the post-operative visit within 2-4 weeks following the procedure. IUD status was known six months post-abortion. |
Measure Participants | 64 | 26 |
Number [percentage of expulsions] |
3.1
|
0
|
Adverse Events
Time Frame | 6 months | |||
---|---|---|---|---|
Adverse Event Reporting Description | ||||
Arm/Group Title | A/Immediate | B/Delayed | ||
Arm/Group Description | The patients in the immediate arm will have the Copper T 380A IUD inserted within 15 minutes after delivery of the placenta immediately following procedure Copper T 380A IUD: Copper T 380A IUD will be placed immediately following the procedure. | The delayed group will have the Copper T 380A IUD inserted at the post-operative visit within 2-4 weeks following the procedure. Copper T 380A IUD: Copper T 380A IUD will be placed at the 2-4 week post-operative visit. | ||
All Cause Mortality |
||||
A/Immediate | B/Delayed | |||
Affected / at Risk (%) | # Events | Affected / at Risk (%) | # Events | |
Total | / (NaN) | / (NaN) | ||
Serious Adverse Events |
||||
A/Immediate | B/Delayed | |||
Affected / at Risk (%) | # Events | Affected / at Risk (%) | # Events | |
Total | 0/104 (0%) | 0/111 (0%) | ||
Other (Not Including Serious) Adverse Events |
||||
A/Immediate | B/Delayed | |||
Affected / at Risk (%) | # Events | Affected / at Risk (%) | # Events | |
Total | 2/104 (1.9%) | 0/111 (0%) | ||
Reproductive system and breast disorders | ||||
Expulsion | 2/104 (1.9%) | 2 | 0/111 (0%) | 0 |
Limitations/Caveats
More Information
Certain Agreements
Principal Investigators are NOT employed by the organization sponsoring the study.
There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
Results Point of Contact
Name/Title | Miriam Cremer MD MPH |
---|---|
Organization | Basic Health International |
Phone | (646) 593-8694 |
miriam.cremer@gmail.com |
- Post Abortion Copper T IUD